Koh Kawasaki
Shizuoka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity.
Journal: European journal of pharmacology
Published: January 16, 2020
Teriparatide relieves ovariectomy-induced hyperalgesia in rats, suggesting the involvement of functional regulation in primary sensory neurons by PTH-mediated signaling.
Journal: Scientific reports
Published: June 04, 2019
Thrombomodulin alfa prevents the decrease in platelet aggregation in rat models of disseminated intravascular coagulation.
Journal: Thrombosis research
Published: February 18, 2019
Thrombomodulin alfa attenuates the procoagulant effect and cytotoxicity of extracellular histones through the promotion of protein C activation.
Journal: Thrombosis research
Published: April 03, 2017
Thrombomodulin alfa attenuates thrombin-induced leakage of antithrombin through suppression of endothelial vascular hyperpermeability.
Journal: Thrombosis research
Published: March 29, 2017
The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats.
Journal: Journal of pharmacological sciences
Published: December 09, 2013
Pleiotropic effects of the rho-kinase inhibitor fasudil after subarachnoid hemorrhage: a review of preclinical and clinical studies.
Journal: Current vascular pharmacology
Published: November 28, 2013
Evidence of a direct cellular protective effect of Rho-kinase inhibitors on endothelin-induced cardiac myocyte hypertrophy.
Journal: Biochemical and biophysical research communications
Published: June 14, 2012
Antivasospastic effects of hydroxyfasudil, a Rho-kinase inhibitor, after subarachnoid hemorrhage.
Journal: Journal of pharmacological sciences
Published: December 22, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026